In Vitro Studies of Sickle Cell Disease Drugs
Find new drugs for the treatment of SCD.
SCD patients with hemoglobin SS, 5 years and up with a Hemoglobin F less than 10% and not receiving hydroxyurea or transfusion therapies.
PI: Dr. Toshio Asakura
SC: Tannoa Jackson
Sponsor: National Institutes of Health